Comera Life Sciences Holdings, Inc. Contracts & Agreements
26 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (2)
- Human Resources (4)
- Mergers & Acquisitions (1)
- Uncategorized (6)
- Form of Senior Secured Convertible Note (Filed With SEC on December 29, 2023)
- Form of Common Stock Warrant (Filed With SEC on December 29, 2023)
- Securities Purchase Agreement, dated December 29, 2023, by and among Comera Life Sciences Holdings, Inc. and the Purchasers defined therein (Filed With SEC on December 29, 2023)
- Separation Agreement and Release, dated October 6, 2023, between the Company and Neal Muni, MD (Filed With SEC on October 6, 2023)
- Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan (as amended through August 31, 2023) (Filed With SEC on September 1, 2023)
- Form of Common Stock Warrant (Filed With SEC on August 1, 2023)
- Securities Purchase Agreement, dated July 31, 2023, by and among the Company and the Purchasers defined therein (Filed With SEC on August 1, 2023)
- Registration Rights Agreement dated July 31, 2023, by and among the Company and the Purchasers defined therein (Filed With SEC on August 1, 2023)
- Offer Letter Agreement dated October 25, 2022, between Comera Life Sciences Holdings, Inc. and Janice McCourt (Filed With SEC on February 3, 2023)
- Form of Common Stock Warrant (Filed With SEC on January 4, 2023)
- Securities Purchase Agreement, dated January 2, 2023, by and among Comera Life Sciences Holdings, Inc. and the Purchasers defined therein (Filed With SEC on January 4, 2023)
- Registration Rights Agreement dated January 4, 2023, by and among Comera Life Sciences Holdings, Inc. and the Purchasers defined therein (Filed With SEC on January 4, 2023)
- Purchase Agreement, dated August 31, 2022, between Comera Life Sciences Holdings, Inc. and Arena Business Solutions Global SPC II, Ltd (Filed With SEC on August 31, 2022)
- Employment Letter Agreement dated as of June 13, 2022 by and between Comera Life Sciences Holdings, Inc. and Michael Campbell (Filed With SEC on June 17, 2022)
- First Amendment to Business Combination Agreement, dated as of May 19, 2022 among the Registrant, OTR Acquisition Corp., CLS Sub Merger 1 Corp., CLS Sub Merger 1 Corp. and Comera... (Filed With SEC on May 25, 2022)
- Comera Life Sciences, Inc. 2022 Incentive Award Plan (Filed With SEC on May 25, 2022)
- Registration Rights and Lock-Up Agreement among the Registrant and certain existing stockholders of Comera and OTR, dated as of May 19, 2022 (Filed With SEC on May 25, 2022)
- Form of Director and Officer Indemnification Agreement (Filed With SEC on May 25, 2022)
- Settlement and Release Agreement made and entered into as of May 19, 2022, between Comera Life Sciences Holdings, Inc. and Maxim Group LLC (Filed With SEC on May 25, 2022)
- Registration Rights Agreement made and entered into as of May 19, 2022, between Comera Life Sciences Holdings, Inc. and Maxim Group LLC (Filed With SEC on May 25, 2022)
- Reform Biologics, Inc. 2021 Stock Option and Grant Plan (Filed With SEC on March 9, 2022)
- Offer Letter Agreement dated September 1, 2021 issued by Reform Biologics, Inc. to Jeffrey S. Hackman (Filed With SEC on March 9, 2022)
- Offer Letter Agreement dated October 17, 2016 issued by Reform Biologics LLC to John M. Sorvillo (Filed With SEC on March 9, 2022)
- Offer Letter Agreement dated September 1, 2021 issued by Reform Biologics, Inc. to Neal Muni (Filed With SEC on March 9, 2022)
- Offer Letter Agreement dated March 14, 2017 issued by Reform Biologics LLC to Robert Mahoney (Filed With SEC on March 9, 2022)
- Letter of promotion dated October 12, 2021 issued by Reform Biologics, Inc. to Robert Mahoney (Filed With SEC on March 9, 2022)
